Summary
This prediction ended on 24.10.22 with a price of €0.64. Massive losses of -93.82% were the result for the BUY prediction by BiotechBee. BiotechBee has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tricida | - | - | - | - |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% | 57.846% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% | 84.823% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% | 54.805% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% | 64.029% |
According to BiotechBee what are the pros and cons of Tricida for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tricida diskutieren
Buy mit Kursziel 25,0